These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 8059409

  • 1. [The ECG changes during the performance of hemodialysis using dialysis solution concentrates with different potassium levels in patients with chronic kidney failure and normokalemia].
    Alavi AA, Riabykina GV, Zaruba AIu, Kutsenko AI, Kukharchuk VV, Eliseev AO.
    Ter Arkh; 1993; 65(4):58-60. PubMed ID: 8059409
    [Abstract] [Full Text] [Related]

  • 2. [Prevention and treatment of cardiac rhythm disorders during hemodialysis].
    Krivoshiev S, Kiriakov Z, Zlatarska S, Antonov S, Vuzelov E.
    Vutr Boles; 1988; 27(3):57-61. PubMed ID: 3206904
    [Abstract] [Full Text] [Related]

  • 3. How should dialysis fluid be individualized for the chronic hemodialysis patient? Potassium.
    Rachoin JS, Weisberg LS.
    Semin Dial; 2008; 21(3):223-5. PubMed ID: 18363596
    [No Abstract] [Full Text] [Related]

  • 4. The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients.
    Heguilén RM, Sciurano C, Bellusci AD, Fried P, Mittelman G, Rosa Diez G, Bernasconi AR.
    Nephrol Dial Transplant; 2005 Mar; 20(3):591-7. PubMed ID: 15687112
    [Abstract] [Full Text] [Related]

  • 5. [Bicarbonate hemodialysis in the therapy of chronic kidney failure].
    Riabov SI, Shostka GD, Spiridonov VN, Vasil'ev AN, Kozlov VV.
    Ter Arkh; 1988 Mar; 60(5):76-80. PubMed ID: 3175934
    [Abstract] [Full Text] [Related]

  • 6. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM, Youssef AM, Zayoon MY.
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [Abstract] [Full Text] [Related]

  • 7. Electrocardiography and serum potassium before and after hemodialysis sessions.
    Tarif N, Yamani H, Bakhsh AJ, Al-Wakeel JS, Sulaimani F, Memon NA, Al Suwaida AK.
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):47-53. PubMed ID: 18087122
    [Abstract] [Full Text] [Related]

  • 8. Occult hypoglycemia caused by hemodialysis.
    Jackson MA, Holland MR, Nicholas J, Talbot M, Spencer H, Lodwick R, Fuhrmann C, Forster D, Macdonald IA.
    Clin Nephrol; 1999 Apr; 51(4):242-7. PubMed ID: 10230557
    [Abstract] [Full Text] [Related]

  • 9. [Experimental and clinical studies of methods for regenerating the dialysis solution].
    Eventov VL, Andrianova MIu, Maksimenko VA.
    Urol Nefrol (Mosk); 1995 Apr; (4):25-7. PubMed ID: 7571196
    [Abstract] [Full Text] [Related]

  • 10. Model-based analysis of potassium removal during hemodialysis.
    Ciandrini A, Severi S, Cavalcanti S, Fontanazzi F, Grandi F, Buemi M, Mura C, Bajardi P, Badiali F, Santoro A.
    Artif Organs; 2009 Oct; 33(10):835-43. PubMed ID: 19681843
    [Abstract] [Full Text] [Related]

  • 11. [The regulation of plasma aldosterone in hemodialysis patients].
    Louis F, Zwahlen A, Favre H, Vallotton M.
    Schweiz Med Wochenschr; 1980 Dec 06; 110(49):1882-4. PubMed ID: 7006078
    [Abstract] [Full Text] [Related]

  • 12. Patients with complex arrhythmias during and after haemodialysis suffer from different regimens of potassium removal.
    Santoro A, Mancini E, London G, Mercadal L, Fessy H, Perrone B, Cagnoli L, Grandi E, Severi S, Cavalcanti S.
    Nephrol Dial Transplant; 2008 Apr 06; 23(4):1415-21. PubMed ID: 18065796
    [Abstract] [Full Text] [Related]

  • 13. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R, Hemodialysis (HEMO) Study Group.
    N Engl J Med; 2002 Dec 19; 347(25):2010-9. PubMed ID: 12490682
    [Abstract] [Full Text] [Related]

  • 14. [Electrochemical regeneration of the dialyzing solution].
    Eventov VL, Andrianova MIu, Maksimenko VA, Nefedkin SI, Ostodi T.
    Urol Nefrol (Mosk); 1997 Dec 19; (2):13-6. PubMed ID: 9206874
    [Abstract] [Full Text] [Related]

  • 15. An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids.
    Arogundade FA, Ishola DA, Sanusi AA, Akinsola A.
    Afr J Med Med Sci; 2005 Sep 19; 34(3):227-33. PubMed ID: 16749353
    [Abstract] [Full Text] [Related]

  • 16. How should dialysis fluid be individualized for the chronic hemodialysis patient? Sodium.
    Flanigan MJ.
    Semin Dial; 2008 Sep 19; 21(3):226-9. PubMed ID: 18363598
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of acetate-free biofiltration with a potassium-profiled dialysate on the control of cardiac arrhythmias in patients at risk: a pilot study.
    Muñoz RI, Montenegro J, Salcedo A, Gallardo I, Martínez I, Quintanilla N, Saracho R, Lekuona I.
    Hemodial Int; 2008 Jan 19; 12(1):108-13. PubMed ID: 18271851
    [Abstract] [Full Text] [Related]

  • 19. Severe post-dialysis hypokalaemia leading to quadriparesis.
    Saif I, Halim A, Altaf A, Saif M, Siddiqui U, Rahman MK, Azam N.
    J Pak Med Assoc; 2008 Jan 19; 58(1):41-3. PubMed ID: 18297977
    [Abstract] [Full Text] [Related]

  • 20. A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients.
    Kaisar MO, Wiggins KJ, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Mudge DW, Bofinger A, Petrie JJ, Johnson DW.
    Am J Kidney Dis; 2006 May 19; 47(5):809-14. PubMed ID: 16632019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.